These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5478343)

  • 1. The effect of Norit extraction on the plasma binding of testosterone in normal men and in women with the polycystic ovary syndrome.
    Southren AL; Olivo J; Gordon GG; Tochimoto S
    Clin Chim Acta; 1970 Nov; 30(2):538-40. PubMed ID: 5478343
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum testosterone levels in the polycystic ovary syndrome. Effect of an estrogen-progestin on protein binding of testosterone.
    Easterling WE; Talbert LM; Potter HD
    Am J Obstet Gynecol; 1974 Oct; 120(3):385-9. PubMed ID: 4415747
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma androgens and sex hormone binding globulin in women with polycystic ovaries diagnosed by transvaginal ultrasound.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    J Reprod Med; 1993 Nov; 38(11):858-62. PubMed ID: 8277481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone and androstenedione metabolism in the polycystic ovary syndrome: studies of the percentage binding of testosterone in plasma.
    Southren AL; Gordon GG; Tochimoto S; Olivo J; Sherman DH; Pinzon G
    J Clin Endocrinol Metab; 1969 Oct; 29(10):1356-63. PubMed ID: 5353663
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome.
    Moll GW; Rosenfield RL
    J Pediatr; 1983 Mar; 102(3):461-4. PubMed ID: 6219196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of medroxyprogesterone acetate on androgen metabolism in the polycystic ovary syndrome.
    Gordon GG; Southren AL; Calanog A; Olivo J; Rafii F
    J Clin Endocrinol Metab; 1972 Sep; 35(3):444-7. PubMed ID: 5051367
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of polycystic ovaries by transvaginal ultrasound and serum androgens.
    Takahashi K; Yoshino K; Eda Y; Kitao M
    Int J Fertil; 1992; 37(5):290-4. PubMed ID: 1358841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a traditional herbal medicine (shakuyaku-kanzo-to) on testosterone secretion in patients with polycystic ovary syndrome detected by ultrasound.
    Takahashi K; Yoshino K; Shirai T; Nishigaki A; Araki Y; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jun; 40(6):789-92. PubMed ID: 3292675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polycystic ovary. 8. The metabolism of 5-pregnendone, progesterone, testosterone, 4-androstenedione and oestrone by normal and polycystic ovarian tissues.
    Axelrod LR; Goldzieher JW
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):255-71. PubMed ID: 6072691
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic and cardiovascular changes in women with polycystic ovary syndrome.
    Meden-Vrtovec H; Vrtovec B; Osredkar J
    Int J Gynaecol Obstet; 2007 Nov; 99(2):87-90. PubMed ID: 17900581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease.
    Andersen RN; Givens JR; Wiser WL; Umstot ES
    Am J Obstet Gynecol; 1976 May; 125(2):166-9. PubMed ID: 944533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of the biologically available fractions of oestradiol and testosterone in plasma.
    Reed MJ; Cheng RW; Beranek PA; Few JD; Franks S; Ghilchik MW; James VH
    J Steroid Biochem; 1986 Jan; 24(1):317-20. PubMed ID: 3702413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma androgens in patients with the polycystic overy syndrome.
    Horton R; Neisler J
    J Clin Endocrinol Metab; 1968 Apr; 28(4):479-84. PubMed ID: 5643867
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome.
    Wild RA; Bartholomew MJ
    Am J Obstet Gynecol; 1988 Aug; 159(2):423-7. PubMed ID: 2970222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease.
    Talbert LM; Sloan C
    Obstet Gynecol; 1979 Jun; 53(6):694-7. PubMed ID: 572024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome.
    Raj SG; Raj MH; Talbert LM; Sloan CS; Hicks B
    Obstet Gynecol; 1982 Jul; 60(1):15-9. PubMed ID: 7201126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Study of Serum Soluble CD 163 Levels in Women with Polycystic Ovary Syndrome.
    Oruç AS; Yilmaz N; İnal HA; Görkem Ü; Gulsen P; Uğur M; Buyukkagnici U
    Horm Metab Res; 2016 Jun; 48(6):399-403. PubMed ID: 26985764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for free testosterone assay: clinical evaluation.
    Falsetti L; Dordoni D; Omodei U; Ghielmi S; Gastaldi C
    Acta Eur Fertil; 1985; 16(5):343-6. PubMed ID: 4082868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.
    Garin MC; Butts SF; Sarwer DB; Allison KC; Senapati S; Dokras A
    Endocrine; 2017 Mar; 55(3):907-913. PubMed ID: 28004236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.